Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Fachpsychotherapie Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber

Live-Webinar "(Cluster-)Kopfschmerzen und Migräne"

Auf den neuesten Stand in Diagnostik und Therapie von (Cluster-)Kopfschmerzen und Migräne bringt Sie das mit 2 CME-Punkten zertifizierte interdisziplinäre Webinar am 20. Februar von 17.30 bis 19 Uhr. Darin geht es um den aktuellen Stand bei Cluster- und trigeminoautonomen Kopfschmerzen, die psychologischen Aspekte und Behandlungsverfahren bei Kopfschmerzen sowie die Behandlungsmöglichkeiten von Migräne. Im Chat haben Sie Gelegenheit, Ihre Fragen an die Experten zu stellen.
Erweiterte Suche
Anmelden
nach oben
General Thoracic and Cardiovascular Surgery
Erschienen in:

07.04.2020 | Special Edition

Lymph node assessment in early stage non-small cell lung cancer lymph node dissection or sampling?

verfasst von: Gail E. Darling

Erschienen in: General Thoracic and Cardiovascular Surgery | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Lymph node assessment is an essential component of the treatment of lung cancer. Identification of the correct “N” stage is important for staging which in turn determines treatment. Assessment of lymph nodes may be accomplished using imaging with CT scan and PET–CT, invasive techniques such as mediastinoscopy, endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) or endoscopic ultrasound fine needle aspiration (EUS-FNA). Ultimately, regardless of any pre-resection assessment, lymph nodes must be assessed at the time of resection. The question to be addressed in this report is the role of mediastinal lymph node dissection versus lymph node sampling. However, the issues surrounding lymph node assessment in NSCLC are complex, depending on clinical stage, imaging and histology.
Literatur
1.
Carlens E. Mediastinoscopy: a method for inspection and tissue biopsy in the superior mediastinum. Dis Chest. 1959;36:343–52.PubMedCrossRef
2.
Silvestri GA. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 suppl):e211s–e250s250s.PubMedCrossRef
3.
Silvestri GA, Gould MK, Margolis ML, Tanoue LT, MCrory D, Toloza E, et al. Noninvasive staging of non-small cell lung cancer. ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 Suppl):178S–201S.PubMedCrossRef
4.
5.
Al-Sarraf N, Gately K, Lucey J, Wilson L, McGovern E, Young V. Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1145 lymph nodes. Lung Cancer. 2008;60(1):62–8.PubMedCrossRef
6.
Ghosh S, Nanjiah P, Dunning J. Should all patients with non-small cell lung cancer who are surgical candidates have cervical mediastinoscopy preoperatively? Interact Cardiovasc Thorac Surg. 2006;5(1):20–4.PubMedCrossRef
7.
Cerfolio RJ, Bryant AS, Eloubeidi MA. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study. Chest. 2006;130(6):1791–5.PubMedCrossRef
8.
Darling GE, Maziak DE, Inculet RI, et al. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial. J Thor Oncol. 2011;6:1367–72.CrossRef
9.
Herth FJF, Eberhardt R, Krasnik M, Ernst A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest. 2008;133(4):887–91.PubMedCrossRef
10.
Yasufuku K, Pierre A, Darling G, et al. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg. 2011;142:1393–400.PubMedCrossRef
11.
Caddy G, Conron M, Wright G, et al. The accuracy of EUS-FNA in assessing mediastinal lymphadenopathy and staging patients with NSCLC. Eur Resp J. 2005;25:410–5.CrossRef
12.
Cahan G. Radical lobectomy. J Thorac Cardiovasc Surgery. 1960;39:555–72.CrossRef
13.
Martini N. Mediastinal lymph node dissection for lung cancer. The Memorial experience. Chest Surg Clin N Am. 1995;5:189–203.PubMed
14.
Kuzdzal J, Warmus J, Grochowski Z. Optimal mediastinal staging in non-small cell lung cancer: What is the role of TEMLA and VAMLA. Lung Cancer. 2014;86:1–4.PubMedCrossRef
15.
Lardinois D, Suter H, Hakki H, et al. Morbidity, survival and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thor Surg. 2005;80:268–74.CrossRef
16.
Osarogiagbon RU, Decker PA, Ballman K, et al. Survival implications of variation in the thoroughness of pathologic lymph node examination in American college of surgeons oncology group Z0030 (Alliance). Ann Thor Surg. 2016;102:363–9.CrossRef
17.
Smeltzer MP, Faris N, Yu X, et al. Missed intrapulmonary lymph node metastasis and survival after resection of non-small cell lung cancer. Ann Thor Surg. 2016;102:448–53.CrossRef
18.
Smeltzer MP, Faris NR, Ray MA, Osarogiagbon RU. Association of pathologic nodal staging quality with survival among patients with non-small cell lung cancer after resection with curative intent. JAMA Oncol. 2018;4:80–7.PubMedCrossRef
19.
Izbicki JR, Passlick B, Pantel K, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg. 1998;227:138–44.PubMedPubMedCentralCrossRef
20.
21.
Wu Y, Huang Z, Wang S, et al. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer. 2002;35:1–6.CrossRef
22.
Keller SM, Adak S, Wagner H, et al. Mediastinal lymph node dissection improves survival in patients with stages II and IIA non-small cell lung cancer. Ann Thor Surg. 2000;70:358–65.CrossRef
23.
Oda M, Watanabe Y, Shimizu J, et al. Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: The role of systematic nodal dissection. Lung Cancer. 1998;22:23–30.PubMedCrossRef
24.
Darling GE, Allen MS, Decker PA, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patients with N0 or N1 ( less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg. 2011;141:662–70.PubMedPubMedCentralCrossRef
25.
Asamura H, Nakayama H, Kondo H, Tsuchiya R, Naruke T. Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg. 1999;117:1102–11.PubMedCrossRef
26.
Okada M, Sakamoto T, Yuki T, et al. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. Ann Thorac Surg. 2006;81:1028–32.PubMedCrossRef
27.
Ishiguro F, Matsuo K, Fukui T, et al. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score. J Thorac Cardiovasc Surg. 2010;139:1001–6. https://​doi.​org/​10.​1016/​j.​jtcvs.​2009.​07.​024.PubMedCrossRef
28.
Maniwa T, Okumura T, Isaka M, et al. Recurrence of mediastinal node cancer after lobe-specific systematic nodal dissection for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2013;44:e59–64.PubMedCrossRef
29.
Adachi H, Sakamaki K, Nishii T, et al. Lobe-specific lymph node dissection as a standard procedure in surgery for non-small-cell lung cancer: A propensity score matching study. J Thorac Oncol. 2017;12:85–93.PubMedCrossRef
30.
Hishida T, Miyaoka E, Yokoi K, et al. Lobe-specific nodal dissection for clinical stage I and II NSCLC: Japanese multi-institutional retrospective study using a propensity score analysis. J Thorac Oncol. 2016;11:1529–37.PubMedCrossRef
31.
Bille A, Woo KM, Ahmad U, et al. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients. Eur J Cardiothorac Surg. 2017;51:674–9.PubMedPubMedCentralCrossRef
32.
Meng D, Zhou Z, Wang Y, et al. Lymphadenectomy for clinical early-stage non-small–cell lung cancer: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2016;50:597–604.PubMedCrossRef
33.
Hishida I, Saji H, Watanabe SI, et al. A randomized phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413). Jpn J Clin Oncol. 2018;48:190–4.PubMedCrossRef
34.
Ramirez RA, Wang CG, Miller LE, et al. Incomplete intrapulmonary lymph node retrieval after routine pathologic examination for resected lung cancer. J Clin Oncol. 2012;30:2823–8.PubMedCrossRef
35.
Lardinois D, De Leyn P, Van Schil P, Porta RR, Waller D, Passlick B, Zielinski M, Lerut T, Weder W. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg. 2006;30(5):787–92.PubMedCrossRef
36.
Samayoa AX, Pezzi TA, Pezzi CM, et al. Rationale for a minimum number of lymph nodes removed with non-small cell lung cancer resection: correlating the number of nodes removed with survival in 98,970 patients. Ann Surg Oncol. 2016;23(suppl 5):1005–111.PubMedCrossRef
37.
Liang W, He J. Shen Y et al Impact of examined lymph node count on precise staging and long-term survival of resected non-small-cell lung cancer: a population study of the US SEER database and a Chinese multi-institutional registry. J Clin Oncol. 2017;35:1162–70.PubMedCrossRef
38.
Noguchi M, Morikawa A, Kowasaki M, et al. Small adenocarcinoma of the lung histologic characteristics and prognosis. Cancer. 1995;75:2844–52.PubMedCrossRef
39.
Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thor Oncol. 2015;10:1243–60.CrossRef
40.
Yuan Y, Ma G, Zhang Y, Chen H. Presence of micropapillary and solid patterns are associated with nodal upstaging and unfavourable prognosis among patients with cT1N0M0 lung adenocarcinoma: a large scale analysis. J Cancer Res Clin Oncol. 2018;144:743–9.PubMedCrossRef
41.
Nasir BS, Yasufuku K, Liberman M. When should negative endobronchial ultrasonography findings be confirmed by a more invasive procedure? Ann Surg Oncol. 2018;2:68–75.CrossRef
Metadaten
Titel
Lymph node assessment in early stage non-small cell lung cancer lymph node dissection or sampling?
verfasst von
Gail E. Darling
Publikationsdatum
07.04.2020
Verlag
Springer Singapore
Erschienen in
General Thoracic and Cardiovascular Surgery / Ausgabe 7/2020
Print ISSN: 1863-6705
Elektronische ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-020-01345-y

Weitere Artikel der Ausgabe 7/2020

Computed tomography screening for lung cancer

  • Special Edition

Uniportal VATS for non-small cell lung cancer

  • Special Edition

Surgery and stereotactic body radiotherapy for early-stage non-small cell lung cancer: prospective clinical trials of the past, the present, and the future

  • Special Edition

The diagnosis and treatment of lung cancer presented as ground-glass nodule

  • Special Edition

New T1 classification

  • Special Edition

Preface

  • Special Edition

Neu im Fachgebiet Chirurgie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Appendizitis und Darminfarkt durch Blinddarm-Lipom

Eigentlich sind Lipome recht harmlos. Im Zäkum können sie jedoch erhebliche Komplikationen mit Darminfarkt und Appendizitis verursachen.

Gluteuslappen nach Rektumkarzinom-Op. schützt vor Abszessen

Die Wunddeckung mit einem autologen Rotationslappen nach Entfernung eines Rektumkarzinoms konnte in einer randomisierten Studie gegenüber dem primären Wundverschluss vor allem in einer Hinsicht punkten: Sie führte deutlich seltener zu präsakralen Abszessen.

Webinar

MedTalk Leitlinie KOMPAKT: S3-Leitline zu peripheren Nervenverletzungen

  • Webinar | 10.02.2025 | 13:00

Über den Weg zur finalen Fassung der S3-Leitlinie "Versorgung peripherer Nervenverletzungen" spricht Prof. Dr. Leila Harhaus-Wähner im MedTalk Leitlinie KOMPAKT. In dem kurzen Video geht es darum, was sich im Vergleich zur vorigen Fassung der Leitlinie geändert hat, welche Aspekte für die tägliche Praxis besonders wichtig sind und was jeder gemäß Leitlinie nun anders oder besser machen sollte.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise